Correction: Reevaluation of the link between systemic lupus erythematosus and cognitive decline or dementia
Overview
This correction addresses an error in a previous meta-analysis regarding the association between systemic lupus erythematosus (SLE) and cognitive impairment or dementia. The corrected odds estimates indicate a higher risk associated with studies having fewer than 1000 SLE cases.
Background
Systemic lupus erythematosus is a complex autoimmune disease that can lead to various neuropsychiatric complications, including cognitive decline and dementia.
Data Highlights
Group
Number of Studies
Odds Ratio (OR)
<1000 SLE cases
2
3.182
≥1000 SLE cases
4
1.473
Key Findings
The study by Wotton 2017 was incorrectly included in the <1000 group.
The corrected odds estimate for studies with fewer than 1000 SLE cases is now 3.182.
Studies with 1000 or more SLE cases have an odds estimate of 1.473.
Both estimates are statistically significant.
Clinical Implications
Clinicians should be aware of the revised odds estimates when assessing the risk of cognitive impairment in SLE patients. Accurate subgroup analyses are critical for informing treatment strategies and patient counseling.
Conclusion
The correction highlights the importance of precise data representation in research on SLE and cognitive decline.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
